Novartis AG Total Liabilities 2012-2026 | NVS

Novartis AG total liabilities for the quarter ending March 31, 2026 were $79.605B, a 29.46% increase year-over-year.

  • Novartis AG total liabilities for 2025 were $64.4B, a 10.81% increase from 2024.
  • Novartis AG total liabilities for 2024 were $58.12B, a 9.26% increase from 2023.
  • Novartis AG total liabilities for 2023 were $53.195B, a 8.33% decline from 2022.

Novartis AG Total Liabilities 2012-2026 | NVS

  • Novartis AG total liabilities for 2025 were $64.4B, a 10.81% increase from 2024.
  • Novartis AG total liabilities for 2024 were $58.12B, a 9.26% increase from 2023.
  • Novartis AG total liabilities for 2023 were $53.195B, a 8.33% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B